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Conclusion. These data suggest that early progressive podo-Early events leading to renal injury in obese Zucker (fatty) rats
cyte damage and macrophage infiltration is associated withwith type II diabetes.
hyperlipidemia and type IIb diabetes mellitus, and antedatesBackground. More than half of the new patients admitted
both the development of glomerulosclerosis and tubulointersti-to dialysis therapy in some centers are diagnosed with type IIb
tial damage.diabetes, that is, diabetes associated with obesity. This study
searched for a common final pathway of renal damage in this
progressive renal disease.
Methods. The evolution of biochemical and morphological In most Western countries, the number of patientsrenal changes was examined in 6- to 60-week-old Zucker rats
with end-stage renal disease is increasing. Recent analy-( fa/fa-rats), a model of obesity associated with type II diabetes.
ses indicate that much of the continuing growth is dueResults. fa/fa-rats exhibited pronounced hyperinsulinemia
and hyperlipidemia at 6 weeks and became diabetic after 14 to patients with type II diabetes mellitus and diabetic
weeks of age. Significant focal segmental glomerulosclerosis nephropathy. In some centers, such patients account for
was first noted in 18-week-old fa/fa-rats and tubulointerstitial more than 50% of new patients admitted for regulardamage and proteinuria in 40-week-old fa/fa-rats. A compari-
dialysis treatment [1]. The majority of these type II dia-son of kidneys of six-week-old fa/fa-and lean control (Fa/?) rats
betic patients suffer from type IIb diabetes, which is theby immunohistology revealed a 1.8-fold increase in glomerular
monocyte/macrophage counts in fa/fa-rats and a significant in- diabetes associated with obesity [1].
crease in de novo desmin expression in podocytes. Electron Various animal models have been employed to gain
microscopy demonstrated an increase in the number of podo- more insight into the pathogenesis of the nephropathycyte mitochondria and intracytoplasmic protein and fat drop-
associated with type IIb diabetes [2]. One of the oldest oflets. Podocyte desmin scores markedly increased until week 18
such models is the obese Zucker rat (fa/fa-rat) [3, 4], inin fa/fa-rats, whereas glomerular monocyte/macrophage counts
peaked at 3.2-fold at week 14. Podocyte desmin expression, which an autosomal recessive mutation of the fa-gene, en-
but not glomerular macrophage infiltration, correlated with dam- coding the leptin receptor, results in hyperphagia, obesity,
age in adjacent tubular cells, as evidenced by their de novo and hyperlipidemia [5]. In addition, these rats are charac-expression of vimentin. Progressive glomerular hypertrophy was
terized by peripheral insulin resistance, hyperinsulin-detected in fa/fa-rats after 10 weeks. GBM width was signifi-
emia, and impaired glucose tolerance [6], as well as, partic-cantly increased in 14-week-old fa/fa-rats as compared with
lean controls. Mesangial cell activation (de novo expression of ularly in males, by mild to severe hyperglycemia [6, 7].
a-smooth muscle actin) and proliferation was low to absent Male fa/fa-rats therefore exhibit most of the metabolic
throughout the observation period in fa/fa-rats. Renal cell abnormalities associated with human type IIb diabetes.death counts (TUNEL) remained unchanged in 6- to 40-week-
With increasing age, fa/fa-rats spontaneously de-old fa/fa-rats. Tubulointerstitial myofibroblast formation and
velop proteinuria and focal segmental glomerulosclerosismatrix accumulation occurred late during the study duration
in fa/fa-rats. (FSGS), ultimately leading to renal failure [3, 8]. The
development of proteinuria and/or FSGS in fa/fa-rats
can be ameliorated by treatment with a 3-hydroxy-3-meth-
1 Both authors contributed equally to this study. ylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor
[9], clofibric acid [9], enalapril [10], or CS-045, an antidia-Key words: diabetes, glomerulosclerosis, hyperlipidemia, podocyte,
interstitial fibrosis. betic agent that potentiates insulin action and reduces
insulin resistance [11]. These intervention studies suggestReceived for publication November 4, 1998
that the pathogenesis of renal damage in fa/fa-rats in-and in revised form June 29, 1999
Accepted for publication August 20, 1999 volves a complex interrelationship of metabolic distur-
bances and/or hemodynamic factors. 2000 by the International Society of Nephrology
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To assess the pathologic renal changes that are in- was determined. FSGS was evaluated by an observer
who was unaware of the origin of the slides and wasduced in fa/fa-rats by the metabolic disturbances and/
or hemodynamic factors, various individual parameters evidenced by segmental increases in glomerular matrix,
segmental collapse and obliteration of capillary lumina,such as macrophage infiltration, mesangial expansion,
FSGS development, or tubulointerstitial damage have and accumulation of hyaline. Such changes were fre-
quently associated with synechial attachments to Bow-been studied [8, 12–14]. However, currently, no compre-
hensive assessment of age-related renal changes, particu- man’s capsule. Tubulointerstitial injury was defined as
inflammatory cell infiltrates, tubular dilation and/or atro-larly in fa/fa-rats with diabetes, has been reported. The
aim of this study was therefore to sequentially and in phy, or interstitial fibrosis. Injury was graded according
to Shih, Hines, and Neilson on a scale of 0 to 4 (0 5parallel evaluate biochemical changes and a variety of
renal (immuno-)histologic parameters in male diabetic normal, 0.5 5 small focal areas of damage, 1 5 involve-
ment of less than 10% of the cortex, 2 5 involvementfa/fa-rats. Because late renal changes in fa/fa-rats, such
as FSGS and tubulointerstitial damage, are relatively of 10 to 25% of the cortex, 3 5 involvement of 25 to
75% of the cortex, 4 5 extensive damage involving morenonspecific and may represent part of a common final
pathway, we focused on renal changes that antedate the than 75% of the cortex) [16]. Granulocyte counts in
glomeruli and the tubulointerstitium were obtained in adevelopment of overt proteinuria, FSGS, and tubuloin-
terstitial damage. similar fashion as macrophage counts (discussed later in
this article).
Oil Red O staining was performed using standard pro-
METHODS
tocols on cryostat sections fixed in 10% formaldehyde.
Experimental design
Immunoperoxidase stainingLean Zucker rats (“controls”) and obese (fa/fa) Zucker
rats were obtained from Charles River Wiga (Sulzfeld, Four micrometer sections of methyl Carnoy’s-fixed
biopsy tissue were processed by a direct or indirect im-Germany). Six male fa/fa-rats each were studied at the
ages of 6, 10, 14, 18, 40, and 60 weeks. Six male control munoperoxidase technique as previously described [15].
Primary antibodies included the following: (a) 1A4, arats each were studied at 6, 14, and 40 weeks of age.
Systolic arterial pressure was measured in conscious re- murine monoclonal antibody to an NH2-terminal syn-
thetic decapeptide of a-smooth muscle actin (Dako,strained rats by tail-cuff plethysmography. In each rat,
a 24-hour urine collection was performed to determine Glostrup, Denmark) [17], (b) D33, a murine monoclonal
IgG1 antibody against human muscle desmin (Dako)proteinuria, and an ethylenediaminetetraacetic acid
(EDTA)-anticoagulated plasma sample was obtained [18], (c) V9, a murine monoclonal IgG1 antibody against
human vimentin (Dako) [19], (d) BU-1, a murine mono-and stored at 2708C for the measurement of insulin,
glucose, lipids, serum creatinine, and urea. The rats were clonal antibody against BrdU [20] containing nuclease
in Tris-buffered saline (Amersham, Braunschweig, Ger-sacrificed four hours after an injection of the thymidine
analogue 5-bromo-29-deoxyuridine (BrdU; 100 mg/kg body many), (e) ED1 (Bioproducts for Science, Indianapolis,
IN, USA), a murine monoclonal IgG antibody to a cyto-wt intraperitoneally; Sigma, Deisenhofen, Germany). After
sacrifice, kidneys were quickly removed and weighed, and plasmic antigen present in monocytes, macrophages, and
dendritic cells [21], ( f) 1A29 (Serotec, Oxford, UK), aa 3 to 4 mm thick longitudinal section of the left kidney
was obtained for (immuno-)histology. Renal tissue was murine monoclonal IgG1 antibody to rat intercellular
adhesion molecule-1 (ICAM-1), (g) affinity-purified poly-studied to assess glomerular and tubulointerstitial injury,
cellular expression of the cytoskeletal proteins a-smooth clonal goat antihuman type III collagen (Southern Bio-
technology, Birmingham, AL, USA), (h) affinity-purifiedmuscle actin, desmin and vimentin, cell proliferation (as
defined by immunostaining for BrdU), cell death [by polyclonal goat antihuman/bovine type IV collagen
(Southern Biotechnology), and (i) an affinity-purifiedterminal desoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL)], infiltrating monocytes/mac- IgG fraction of polyclonal rabbit antirat fibronectin
(Chemicon, Temecula, CA, USA).rophages, and extracellular matrix proteins (types III and
IV collagen, fibronectin). For all biopsies, negative controls consisted of substi-
tution of the primary antibody with equivalent concen-
Renal morphology trations of an irrelevant murine monoclonal antibody or
normal rabbit or goat IgG. Evaluation of all slides wasTissue for light microscopy and immunoperoxidase
staining was fixed in methyl Carnoy’s solution [15] and performed by an observer who was unaware of the origin
of the slides.was embedded in paraffin. Four micrometer sections
were stained with the periodic acid-Schiff (PAS) reagent To obtain mean numbers of proliferating cells or infil-
trating monocytes/macrophages in glomeruli, more thanand counterstained with hematoxylin. The percentage
of glomeruli exhibiting focal or global glomerulosclerosis 30 consecutive cross-sections of glomeruli (range 30 to
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Table 1. Metabolic characteristics of fa/fa-rats and age-matched lean control rats
Plasma
Age Body weight Glucose Insulin Triglycerides Cholesterol LDL-cholesterol VLDL-cholesterol HDL-cholesterol
weeks g mg/dL lU/mL mg/dL mg/dL mg/dL mg/dL mg/dL
fa/fa-rats
6 141617b 79627 30 67b 171642b 131631b 564 663 120628b
10 263614a 93613 ND 3476113a 138621 3 62 863 127621
14 416610ab 123619ab 56616b 3366113ab 192629ab 669 768 179622ab
18 450620a 168635a 4968a 463689a 255648a 763 1764a 232654a
40 548638ab 159643ab 44633ab 5966104ab 256677ab 1162a 866 237680a
60 505652a ND ND ND ND ND ND ND
Control rats
6 10864 72 657 ,8 71623 93 618 6 64 563 84615
14 251614c 73627 11 65 48 610c 86616 6 64 565 75613
40 448617c 81624 10 63 67 615 97 617 ND ND ND
Data are mean 6 SD; N 5 6 each; ND is not determined.
a P , 0.05 versus 6-week-old fa/fa-rats
b P , 0.05 versus age-matched control rats
c P , 0.05 versus 6-week-old lean control rats
Table 2. Blood pressure, renal functional and morphological findings in fa/fa-rats and age-matched lean control rats
Mean systolic 2 Kidney Plasma Urinary protein Tubulointerstitial
Age blood pressure weight Kidney weight creatinine Plasma urea excretion FSGS damage
weeks mm Hg mg % of body wt lmol/L mmol/L mg/day % score
fa/fa-rats
6 ND 581640 0.2160.02 5565 10 62 6 67 0.060.0 0.0 60.0
10 ND 12976109a 0.2560.01 4863a 961 7 62 0.360.8 0.0 60.0
14 10267 16536163ab 0.2060.02 5566 10 62b 1264 0.060.0 0.0 60.0
18 110614 1613669a 0.1860.01a 5168 11 62 33 633 3.861.6a 0.360.4
40 11469 16166144ab 0.1160.01ab 4967 8 61 1456131ab 6.462.6ab 0.660.2ab
60 156611 ND ND 103647a 1367 340628a 46.7614.4a 3.260.7a
Control rats
6 ND 507667 0.2460.03 52617 8 62 2 61 0.760.5 0.0 60.0
14 109617 880 699c 0.1860.02 5465 7 61 1165c 0.560.4 0.0 60.0
40 11968 1141643c 0.1360.00c 5664 6 61c 2069c 1.561.3c 0.160.2
Data are mean 6 SD; N 5 6 each; ND is not determined.
a P , 0.05 versus 6-week-old fa/fa-rats
b P , 0.05 versus age-matched control rats
c P , 0.05 versus 6-week-old lean control rats
100) were evaluated, and mean values per kidney were also are highly correlated with those obtained by compu-
terized morphometry [22, 23].calculated. To obtain total counts of proliferating cells
or infiltrating monocytes/macrophages in the renal cortex In the case of immunostaining for a-smooth muscle
actin and desmin, the periglomerular areas were assessedor medulla, over 30 grid fields (range, 30 to 50), measur-
ing 0.36 mm2 each, were analyzed, and again, mean separately. Semiquantitative staining scores in these cases
depended on the percentage of the interstitium immedi-counts per kidney were obtained. For the evaluation of
the immunoperoxidase stains for a-smooth muscle actin, ately contiguous to Bowman’s capsule showing positive
staining: 0 5 0 to 5% stained, I 5 5 to 25%, II 5 25 todesmin, and vimentin, each glomerular area or tubuloin-
terstitial grid field was graded semiquantitatively, and 50%, III 5 50 to 75%, and IV 5 .75%. Finally, in the
case of immunostaining for desmin, the outer cell layerthe mean score per biopsy was calculated. Each score
reflects mainly the changes in the extent rather than of the glomerular tuft was evaluated separately using
the same scoring system.intensity of staining, and depended on the percentage
of the glomerular tuft area or grid field showing positive To analyze planar glomerular areas in renal sections
immunostained for desmin, the outer edges of all glomer-staining: 0 5 absent staining or less than 5% of the area
stained, I 5 5 to 25%, II 5 25 to 50%, III 5 50 to 75%, ular tufts (range 86 to 142) of each kidney were traced
manually on a video screen, and the encircled areas wereand IV 5 .75%. We and others have recently described
that this semiquantitative scoring system is not only re- determined by computerized morphometry (Kontron
Electronic System KS 300, Eching, Germany).producible among different observers, but that the data
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Fig. 1. a-Smooth muscle actin. Immuno-
staining scores for a-smooth muscle actin in
the various renal compartments of fa/fa-rats
(d) and lean control rats (h). Data are mean 6
sd. *P , 0.05 vs. 6-week-old fa/fa-rats; #P ,
0.05 vs. age-matched lean control rats.
Fig. 2. Desmin. (A) Immunostaining scores
for desmin in the various renal compartments
of fa/fa-rats (d) and lean control rats (h).
Data are mean 6 sd. *P , 0.05 vs. 6-week-
old fa/fa-rats; #P , 0.05 vs. age-matched lean
control rats. (B) Renal desmin immunostain-
ing in a 6-week-old fa/fa-rat. Desmin expres-
sion mostly exhibits a normal pattern in that
it is confined to the mesangium. However,
focal up-regulation is present in a cell (insert;
magnification 31000) at the glomerular edge
(3200). (C) Renal desmin immunostaining in
a 40-week-old fa/fa-rat. Desmin expression is
markedly up-regulated in glomeruli, whereas
the cortical interstitium exhibits only very
small foci of desmin up-regulation (3200).
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Fig. 2. (Continued)
Fig. 3. Glomerular hypertrophy. Glomerular
area measurements in lean control rats (all
glomeruli; ) and fa/fa-rats [(j) all glomeruli;
(h) glomeruli with desmin score #1; ( ) glo-
meruli with a desmin score .1)]. Data are
means 6 sd of either all glomeruli pooled
or given separately in fa/fa-rats as areas of
glomeruli with a normal immunostaining pat-
tern and score for desmin (mesangial stain,
glomerular edge staining score 0) or with an
abnormal desmin staining pattern and score
(glomerular edge staining score $1).
To analyze the spatial relationship between increased circle of 9 3 1024 mm2 squares (range, 10 to 20 squares)
that were superimposed on tubular profiles immediatelydesmin expression and proteinuria, serial formaldehyde-
fixed sections were immunostained for desmin and stained adjacent to Bowman’s capsule. The number of intracellu-
lar protein droplets was evaluated separately for thosewith Masson’s trichrome stain. The number of intracellu-
lar protein reabsorption droplets was then counted in a glomeruli with normal desmin expression and those with
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Fig. 4. Vimentin. (A) Immunostaining scores for vimentin in the renal
cortex of (d) fa/fa-rats and (h) lean control rats. Data are mean 6 sd.
*P , 0.05 vs. 6-week-old fa/fa-rats; #P , 0.05 vs. age-matched lean
control rats. (B) Double immunostaining for vimentin (red reaction
product) and desmin (black reaction product) in the renal cortex of a
six-week-old fa/fa-rat. Desmin expression is confined to the mesangium
(arrow) and vimentin to mesangial cells and podocytes (arrowheads).
No tubular staining for vimentin is noted (3200). (C) Double immuno-
staining for vimentin (red reaction product) and desmin (black reaction
product) in the renal cortex of an 18-week-old fa/fa-rat. Desmin expres-
sion is up-regulated in podocytes. Adjacent tubules exhibit de novo
staining for vimentin (arrowheads; 3200).
present desmin expression in podocytes (as identified in To identify proliferating glomerular mesangial cells
and proliferating monocyte/macrophages, sections wereserial sections).
also double immunostained for a-smooth muscle actin
Immunohistochemical double staining or ED1, respectively, and BrdU using the same protocol
as outlined previously.Double immunostaining for desmin and vimentin was
performed as reported previously [23] by first staining
TUNEL-staining for the detection of renal cell deaththe sections with the vimentin IgG1 antibody (discussed
previously in this article) using an immunoalkaline phos- In situ detection of cell death was performed using
TUNEL as described [24]. Briefly, 4 mm sections of form-phatase procedure and a red color reaction product. Sec-
tions were then incubated with the IgG1 monoclonal aldehyde fixed tissue were deparaffinized, rehydrated,
and submitted to microwave antigen retrieval in citricantibody against desmin using an immunoperoxidase
procedure and a black reaction product. Negative con- acid buffer. Nuclear proteins were then stripped using
proteinase K (Boehringer Mannheim, Mannheim, Ger-trols included omission of either of the primary antibod-
ies in which case no double staining was noted. many). Next, the slides were incubated with terminal
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Table 4. Relationship between desmin expression at the edge ofTable 3. Relationship between desmin expression at the edge of
the glomerular tuft and de novo vimentin expression in the glomerular tuft and numbers of protein reabsorption
droplets in adjacent tubular cellsadjacent tubular cells
Glomerular edge desmin score Tubular protein reabsorption dropletsa
adjacent to glomeruli with
Normal Increased edge desmin score
Adjacent tubular vimentin score Age weeks Normalb Increasedb
Normal N 5 556 N 5 138
Increased N 5 30 N 5 146 fa/fa-rats
6 1364 15 62Data represent 870 individual scores determined in 30 high power fields each
10 1562 19 62cper biopsy of 6, 10, 14, 18 and 40 week-old fa/fa-rats (N 5 6 each, except for
14 1663 21 63cweek 40 where N is 5). Normal scores are 0; increased scores are $1. Fisher’s
Control ratsexact test, P , 0.0001.
14 1463 —
a See Methods section for details. Thirty-six glomerular profiles (i.e., 6 per
rat) of sequential cortical glomeruli were evaluated per group
b Normal scores, 0; increased scores, $1
desoxynucleotidyl transferase (Pharmacia, Freiburg, Ger- c P , 0.05 versus glomeruli with normal desmin expression
many) and biotin-14-dATP (GIBCO BRL, Eggenstein,
Germany) for one hour at room temperature. After wash-
ing, incorporated biotinylated ATP was detected using
Plasma glucose was determined after overnight fastingthe ABC kit (Vector, Burlingame, CA, USA) and diami-
by clinical routine methods.nobenzidine (DAB) plus nickel. Slides were then coun-
terstained with methyl green and coverslipped. Positive Statistical analysis
controls included a DNAse control (DNAse 1; Sigma) in
All values are expressed as mean 6 sd. Statisticalwhich all nuclei exhibited positive staining. For negative
significance (defined as P , 0.05) was evaluated usingcontrols, biotin-14-ATP was omitted, resulting in no nu-
Student’s t-tests or Mann-Whitney U-tests where appro-clear staining.
priate. Correlations were calculated using Spearman’s
correlation for nonparametric populations.Electron microscopy
One mm3 blocks of renal tissue were fixed in formalde-
hyde (2%)–glutaraldehyde (2.5%) solution according to RESULTS
Karnovsky with cacodylate buffer (0.2 mol/L, pH 7.4). Metabolic abnormalities in young and aging fa/fa-rats
After 48 hours, samples were embedded in araldite, and The body weight in six-week-old fa/fa-rats was already
ultrathin sections were contrasted with lead citrate and significantly higher than that of age-matched lean Zucker
viewed in a Zeiss EM 900. The width of the glomerular rats and remained so in aging fa/fa-rats (Table 1). Obesity
basement membrane (GBM) was determined using the was paralleled by progressive hyperinsulinemia and hyper-
method of Ireland, Patnaik, and Duncan [25]. lipidemia, both of which were already pronounced at the
earliest study time point, that is, in six-week-old fa/fa-ratsMiscellaneous measurements
(Table 1). Hyperlipidemia was due to markedly elevated
Urinary protein was measured using the Bio-Rad Pro- plasma triglyceride and total cholesterol, particularly
tein Assay (Bio-Rad Laboratories GmbH, Munich, Ger- HDL cholesterol levels (Table 1). Mild hyperglycemia
many) and bovine serum albumin (Sigma Chemical was first noted in 14-week-old fa/fa-rats and persisted
Corp., St. Louis, MO, USA) as a standard. thereafter (Table 1). In aging lean control rats, none of
Creatinine and urea were measured using an autoana- the previously mentioned features were noted (Table 1).
lyzer (Beckman Instruments GmbH, Munich, Germany).
Blood pressure, renal functional, and light microscopicInsulin concentrations were measured using a commer-
changes in young and aging fa/fa-ratscially available radioimmunoassay (Pharmacia, Uppsala,
Sweden). Cholesterol and triglyceride levels were deter- Both fa/fa-rats and lean controls exhibited normoten-
mined after overnight fasting colorimetrically by the cho- sive and comparable blood pressure readings at all time
lesterol oxidase/peroxidase and glycerolphosphate oxi- points investigated prior to week 60, and increased at
dase/peroxidase reactions (CHOD-PAPt test kit and week 60 in fa/fa-rats (Table 2).
Peridochromt test kit; Immuno, Heidelberg, Germany). Although kidney weight rose with increasing body
The lipoprotein subfractions very low-density lipoprotein weight, the relative kidney weight decreased in both rat
(pre–b-cholesterol), low-density lipoprotein (b-choles- strains to a similar degree (Table 2). Renal function, as
terol), and high-density lipoprotein (HDL; a-cholesterol) assessed by plasma creatinine and urea, remained normal
were determined by qualitative and quantitative lipid during the observation period until week 40 and increased
thereafter. Progressive proteinuria was noted in fa/fa-electrophoresis as described [26].
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Fig. 6. Monocyte/macrophage influx. Counts
of ED1-positive monocytes/macrophages in
the various renal compartments. Data are
mean 6 sd. *P , 0.05 vs. 6-week-old fa/fa-
rats; #P , 0.05 vs. age-matched lean control
rats.
rats and markedly exceeded the physiologic mild increase activated mesangial cells and interstitial (myo-)fibroblasts
[28, 30]. In aging fa/fa-rats, a very low-grade increase inin proteinuria observed in lean controls (Table 2).
By light microscopy, mild progressive focal and seg- glomerular a-smooth muscle actin expression was first
noted in 10-week-old animals and remained steady there-mental glomerulosclerosis as well as tubulointerstitial
damage developed in aging fa/fa-rats (Table 2). after (Fig. 1). In contrast, in the cortical and medullary
tubulointerstitium, progressive de novo expression ofOil Red O staining demonstrated rare small or absent
lipid deposits in glomeruli and the renal tubulointersti- a-smooth muscle actin occurred from 14 to 18 weeks
onward in fa/fa-rats but not lean control rats (Fig. 1).tium of 6-week-old fa/fa-rats, as well as 14-week-old lean
controls. In contrast, fa/fa-rats aged 10 or 14 weeks old The normal glomerular expression of desmin in most
rat strains is confined to mesangial cells, and podocytesexhibited a progressive accumulation of lipid droplets in
the tubulointerstitium. only express it following various types of injury [27, 28].
In six-week-old fa/fa-rats, one of the two significant immu-
Assessment of renal cellular damage using the nohistochemical changes in comparison to age-matched
immunohistochemical expression of lean controls was an apparent de novo expression of des-
cytoskeletal proteins min in individual podocytes (Fig. 2 A, B). This led to a
small yet significant increase in the desmin staining scoreIn lean controls, the intrarenal expression of a-smooth
muscle actin, desmin, and vimentin was identical to that of the glomerular edge, which then progressively increased
until week 18 in fa/fa but not lean control rats (Fig. 2A).previously described in normal rats [27–29]: a-smooth
muscle actin was confined to arterial smooth muscle cells, The glomerular de novo expression of desmin was associ-
ated with glomerular hypertrophy in the fa/fa-ratsdesmin to smooth muscle cells and mesangial cells, and
vimentin to smooth muscle cells, mesangial cells, and po- (Fig. 3). In addition to the increased desmin expression
in glomeruli of aging fa/fa-rats, low-grade overexpressiondocytes.
In diseased kidney, the de novo expression of a-smooth in the medullary tubulointerstitium was also present in
aging fa/fa-rats (Fig. 2 A, C).muscle actin has been demonstrated to specifically label
b
Fig. 5. Electron microscopy findings. (A) Ten-week-old fa/fa-rat. Podocytes with activated cytoplasm, vacuoles (arrowheads) and prominent
protein droplets (arrows) and mitochondria. This shows a normal remaining ultrastructure (magnification 33000). (B) Ten-week-old fa/fa-rat.
Higher magnification of (A) illustrating a podocytic protein droplet (arrowhead; magnification 312,000) (C) Fourteen-week-old fa/fa-rat. This shows
a normal glomerular ultrastructure except for a podocyte with numerous mitochondria (arrow; magnification 33000). (D) Fourteen-week-old fa/fa-
rat. This shows a podocyte with densely appearing mitochondria (arrow; magnification 312,000). (E) Fourteen-week-old lean control rat with normal
glomerular ultrastructure (magnification 33000). (F) A 14-week-old lean control rat with normal podocyte ultrastructure (magnification 312,000).
Coimbra et al: Renal findings in obese Zucker rats176
Fig. 7. Intercellular adhesion molecule-1 (ICAM-1). (A) Sixteen-week-
old fa/fa-rat. ICAM-1 expression is minimal to absent in glomeruli and
tubular cells. (B) Fourteen-week-old fa/fa-rat. ICAM-1 is expressed on
rare, individual cells in a mesangial location (arrow). (C) Eighteen-
week-old fa/fa-rat. ICAM-1 is weakly expressed within the glomerular
tuft and more strongly in parietal glomerular epithelial cells as well as
the brush border of some tubular cells (arrow; magnification 3400).
To assess whether glomerular podocyte damage is par- 0.93, P , 0.0001). If instead of mean scores per biopsy
alleled by damage of tubular cells, we also immunostained all individual podocyte desmin and tubular vimentin
the renal sections for vimentin, which is expressed de scores of each biopsy were pooled (Table 3), only 5%
novo by damaged tubular cells [27]. As shown in Figure of the glomeruli with normal desmin expression were
4A, cortical tubulointerstitial vimentin scores were sig- surrounded by tubules with an abnormal vimentin ex-
nificantly increased in 14-week-old fa/fa-rats and pro- pression. In contrast, the occurrence of glomeruli with
gressively increased thereafter. increased podocytic desmin expression in an area of nor-
In an attempt to investigate the spatial relationship of mal tubular vimentin expression was much more frequent
podocyte desmin and tubular vimentin overexpression (51% of the cases; Table 3).
in the corresponding nephron, the sections were double
We also assessed the spatial relationship of increases inimmunostained for these two proteins. As shown in Fig-
glomerular podocytic desmin expression and increasedure 4B, glomeruli with a normal desmin staining pattern
protein leakage. The latter was analyzed by counting thewere often surrounded by vimentin negative tubular
number of protein reabsorption droplets in tubules adja-cells. In glomeruli with desmin overexpression in podo-
cent to the glomeruli. As shown in Table 4, increasedcytes, adjacent tubule segments frequently exhibited de
podocytic desmin expression was associated with an in-novo expression of vimentin (Fig. 4C). Mean desmin
creased number of protein reabsorption droplets in adja-scores at the edge of the glomeruli and tubulointerstitial
vimentin scores per biopsy were highly correlated (r 2 5 cent tubules.
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Table 5. Summary of age-related renal changes in fa/fa-rats Podocyte foot processes and the remaining glomerular
ultrastructure, particularly mesangial cells, were wellfa/fa-rats compared to: 6-Week-old Age-matched
fa/fa-rats lean control rats preserved in 14-week-old fa/fa-rats. Fourteen-week-old
Age weeks 10 14 18 40 6 14 40 lean control rats exhibited a normal glomerular and in
particular podocyte morphology (Fig. 5 E, F).Proteinuria → → → ↑ → → ↑
Serum creatinine ↓ → → → → → → To assess whether diabetic fa/fa-rats develop renal
FSGS → → ↑ ↑ → → ↑ changes typical of diabetic nephropathy, the width of
Tubulointerstitial damage → → → ↑ → → ↑
the GBM was determined in 14-week-old fa/fa-rats, thatGlomerular planar area ↑ ↑ ↑ ND → ↑ ND
Cell proliferation is, the first time point with significant hyperglycemia
glomerular → → → ↑ → → ↑ (Table 1), as well as in lean controls. GBM width in
cortical → → → ↑ → → ↑
14-week-old fa/fa-rats was 164.0 6 9.2 nm, which wasmedullary → → → → → → →
Apoptoses significantly higher than that observed in age-matched
glomerular → → → → → → → lean controls (152.5 6 7.8 nm, P , 0.04). In fa/fa-rats,
cortical → → → → → → →
the GBM width thereafter increased further to 198.2 6medullary → → → → → → →
a-SM actin 12.2 nm at 40 weeks of age (P , 0.01 vs. 14-week-old
glomerular (↑) (↑) (↑) (↑) → (↑) (↑) fa/fa-rats).
capsular → → (↑) → → (↑) (↑)
cortical → ↑ ↑ ↑ → ↑ ↑
Leukocyte influx, intercellular adhesion molecule-1medullary → → ↑ ↑ → → ↑
Desmin expression, cell proliferation, and cell death in kidneys
glomerular ↑ ↑ ↑ ↑ → ↑ ↑ of young and aging fa/fa-rats
glomerular edge ↑ ↑ ↑ ↑ (↑) ↑ ↑
cortical → → → (↑) → → → Counts of glomerular monocyte/macrophages were el-
medullary → (↑) → → → (↑) (↑) evated 1.8-fold in fa/fa-rats compared with lean controls
Vimentin
at six weeks (Fig. 6). Glomerular monocyte/macrophagecortical → (↑) ↑ ↑ → (↑) →
Monocytes/macrophages infiltration peaked at week 14 and decreased thereafter
glomerular → ↑ ↑ → ↑ ↑ ↑ (Fig. 6). In the tubulointerstitium of fa/fa-rats, monocyte/
cortical → ↑ → ↑ → ↑ ↑
macrophage counts also peaked at 14 weeks of age andmedullary → ↑ ↑ → → ↑ ↑
ICAM-I decreased thereafter (Fig. 6). Granulocyte counts in both
glomerular → (↑) ↑ (↑) → (↑) (↑) glomeruli and the tubulointerstitium of fa/fa-rats were
cortical → → ↑ (↑) → → (↑)
low and comparable to age-matched lean control rats atmedullary → → ↑ (↑) → → (↑)
Collagen III all time points (data not shown).
glomerular → → → → → → → The expression pattern of ICAM-1 was similar in lean
cortical → → → → → → →
control rats of all ages, as well as in fa/fa-rats at 6 andmedullary → → → → → → →
Collagen IV 10 weeks of age in that occasional glomerular and peritu-
glomerular → → → ↑ → (↑) ↑ bular endothelial cells exhibited faint staining (Fig. 7A).
cortical → → → ↑ → → ↑
At 14 weeks and more pronounced at 18 weeks, in-medullary → → → ↑ → → ↑
Fibronectin creased expression of ICAM-1 in fa/fa-rats was noted in
glomerular → (↑) ↑ ↑ → (↑) ↑ rare glomeruli (mostly in a mesangial and endothelial
cortical → → ↑ ↑ → → (↑)
pattern; Fig. 7B), parietal glomerular epithelial cells, andmedullary (↑) (↑) ↑ → → (↑) →
focally in the tubulointerstitium in areas of tubular injurySymbols are: →, (↑), ↑, ↓, no change, statistically significant but minimal increase,
increase, or decrease. (Fig. 7C and Table 5).
ND is not determined. Glomerular cell proliferation, as assessed by nuclear
BrdU incorporation, increased at 40 weeks of age in fa/fa-
rats (Fig. 8). By double immunostaining for a-smooth
muscle actin and BrdU, this increase was not due to anElectron microscopic findings in kidneys of young
increase in proliferating mesangial cells (data not shown).and aging fa/fa-rats
Rather, proliferating monocytes/macrophages appeared
By electron microscopy, podocyte morphology and to at least partially account for the increase, as double-
glomerular ultrastructure were normal in six-week-old labeled ED1/BrdU-positive cell counts increased from
fa/fa-rats and lean controls (data not shown). In 10-week- 1.1 6 0.3 ED1/BrdU-positive cells per 100 glomerular
old fa/fa-rats, the first evidence of podocyte activation cross sections (6-week-old fa/fa-rats) to 3.1 6 0.9 (40-
and damage was noted, as evidenced by a rise the number week-old fa/fa-rats, P , 0.05 vs. 6-week-old rats). Cell
of mitochondria, sometimes with electron-dense matrix; proliferation in the renal tubulointerstitium remained
furthermore, intracytoplasmic protein and fat droplets constant in aging fa/fa-rats, except for the cortical tubu-
could be demonstrated (Fig. 5 A, B). These changes were lointerstitium, in which a late increase at 40 weeks was
noted (Fig. 8). This later increase was due to a significantmore pronounced in 14-week-old fa/fa-rats (Fig. 5 C, D).
Coimbra et al: Renal findings in obese Zucker rats178
Fig. 8. Cell proliferation. Counts of BrdU-
positive cells in the various renal compart-
ments (mean 6 sd) of (d) fa/fa-rats and (h)
lean control rats. *P , 0.05 vs. 6-week-old fa/
fa-rats; #P , 0.05 vs. age-matched lean control
rats.
increase in tubular cell BrdU incorporation while the DISCUSSION
proliferation of nontubular cells failed to reach statistical In this study, we used male fa/fa-rats to assess the renal
significance (tubular BrdU-positive cells per 0.36 mm2, consequences of prolonged hyperlipidemia, hyperinsu-
0.47 6 0.22 at 40 weeks vs. 0.15 6 0.07 at 6 weeks, P , linemia, and diabetes. Male fa/fa-rats, as compared with
0.05; nontubular BrdU-positive cells per 0.36 mm2, 0.60 6 females, offer the advantages of a more consistent devel-
0.40 at 40 weeks vs. 0.26 6 0.18 at 6 weeks, P 5 NS). opment of overt diabetes [7] and of a relatively slow
Cell death rates, as detected by TUNEL, remained evolution of renal damage [32], which allows for better
constant and comparable during the observation period distinction of individual pathogenetic steps. At the first
in both fa/fa and lean control rats in the glomerular, time point studied, that is, six weeks, fa/fa-rats already
tubular, and interstitial compartments (data not shown). exhibited markedly elevated plasma levels of insulin,
triglycerides, and HDL cholesterol (in contrast to humans,
Extracellular matrix accumulation in kidneys of young HDL particles represent the primary lipoprotein fraction
and aging fa/fa-rats in rats, and hypercholesterolemia in rats typically consists
Extracellular matrix accumulation was assessed by im- of increased serum levels of HDL) [33, 34]. As summa-
munostaining for types III and IV collagen and fibronec- rized in Table 5, a comparison of renal changes in these
tin. The staining pattern in six-week-old fa/fa-and lean very young fa/fa-rats with age-matched lean (Fa/?) rats
control rats was comparable to that previously described revealed only two significant differences, namely an ap-
in normal rats [31]. In fa/fa-rats, both type IV collagen parent de novo expression of desmin at the edge of the
and fibronectin staining scores showed mild increases in glomerular tuft, and a 1.8-fold increase in glomerular
the glomerular and/or tubulointerstitial compartment at monocyte/macrophage counts.
some points past 10 weeks of age (Fig. 9). Immunostain- De novo expression of desmin at the glomerular edge
ing for type III collagen was confined to the renal intersti- rapidly progressed in fa/fa-rats to affect about 25% of
tium in fa/fa and lean rats of all ages, and no de novo the glomerular circumference at 18 weeks (Fig. 2). It has
expression in glomeruli was noted. In aging fa/fa-rats, been shown that desmin expression at the glomerular edge
few foci of expanded interstitial staining for type III labels podocytes, which have been damaged by intra-
glomerular hypertension, immune-mediated or toxic in-collagen were noted, which, however, were not sufficient
to increase significantly the staining scores even in 40- jury, or yet unknown mechanisms, as in the FSGS-prone
Milan normotensive (MNS) rat [27, 35, 36]. Also, podo-week-old rats (6-week-old fa/fa-rats, 1.35 6 0.10 vs. 40
weeks, 1.48 6 0.11, P 5 0.08; Table 5). cytic desmin expression can be prevented by maneuvers
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Fig. 9. Extracellular matrix proteins. (A) Im-
munostaining scores for type IV collagen in
the various renal compartments (mean 6 sd)
of (d) fa/fa-rats and (h) lean control rats. *P ,
0.05 vs. 6-week-old fa/fa-rats; #P , 0.05 vs.
age-matched lean control rats. (B) Immuno-
staining scores for fibronectin in the various
renal compartments (mean 6 sd). *P , 0.05
vs. 6-week-old fa/fa-rats; #P , 0.05 vs. age-
matched lean control rats.
that reduce glomerular injury [27]. Similar to findings in early progressive podocyte injury is a central event in the
pathogenesis of FSGS and subsequent renal failure [37].MNS rats, in fa/fa-rats the early increase in podocyte
desmin expression antedated detectable electron micro- What is the origin of podocyte damage in young fa/fa-
rats? Intervention studies in which proteinuria and/orscopical changes in podocytes [35]. However, the func-
tional relevance of desmin as a marker of podocyte dam- FSGS and renal damage were reduced often did not allow
identification of individual pathogenetic factors. Treat-age is emphasized by our demonstration of increased
tubular protein reabsorption droplets in the vicinity of ment of young fa/fa-rats with enalapril or drugs that im-
prove hyperinsulinemia and glucose tolerance (acarbose,desmin-positive podocytes. Our findings in fa/fa-rats there-
fore suggest that they represent a further example in which CS-045) led to parallel reductions of blood pressure and
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hyperlipidemia [10, 11, 38]. Nevertheless, hypertensive of oxygen radicals, no direct evidence for this hypothesis
is currently available. Furthermore, in fa/fa-rats andpodocyte damage in fa/fa-rats appears unlikely given that
young fa/fa-rats are normotensive both on a systemic other hyperlipidemic rats, increased glomerular mono-
cyte/macrophage counts can be dissociated from the de-(Table 2) and intraglomerular level [4, 39]. Others have
proposed hyperinsulinemia as a central factor in the velopment of FSGS [46, 52, 53]. Finally, signs of glomeru-
lar macrophage activation, such as the expression of classpathogenesis of FSGS in fa/fa-rats [38]. An argument
against this hypothesis is the observation that by aerobic II MHC (Ia) antigens, are not present in young as op-
posed to nine-month-old fa/fa-rats [12, 14].training of diabetic fa/fa-rats, both albuminuria and renal
structural damage were reduced despite persistence of A third, relatively early pathological event in fa/fa-
rats was the development of glomerular hypertrophythe hyperinsulinemia [40]. More importantly, we recently
reported that hyperinsulinemic Goto-Kakizaki (GK) rats (Table 5), which is considered a key event in progressive
glomerular damage [54]. Early hypertrophy in fa/fa-ratswith type II diabetes fail to develop FSGS or albuminuria
[41]. However, it is of interest to note that despite the is partially due to accumulation of fibronectin (Fig. 9)
[55] and mild increases in glomerular proteoglycan andfailure to develop FSGS, podocytes of hyperinsulinemic
GK rats did exhibit some desmin expression and electron type IV collagen content [56, 57], the latter of which
may have been too low to be detectable with our semi-microscopical changes (for example, signs of cellular acti-
vation) [41]. This suggests that hyperinsulinemia and/or quantitative assessment. In addition, it has been pro-
posed that mesangial cell proliferation and activationthe diabetic milieu may result in mild podocyte injury
or cellular activation, which per se is not sufficient to also contribute to glomerular hypertrophy [9, 52]. How-
ever, in young fa/fa-rats, we detected either no or onlyinduce progressive cell damage and FSGS. Our com-
bined observations in GK and fa/fa-rats therefore stress minimal increases in glomerular cell proliferation or
a-smooth muscle actin overexpression, which is a sensi-the importance of second stimuli for the development
of nephropathy in type II diabetes and possibly mirror tive maker of mesangial cell activation [28]. This later
finding is also supported by our and Lavaud et al’s [14]the clinical situation, in which nephropathy only devel-
ops in a fraction of the patients [1]. failure to detect de novo glomerular expression of inter-
stitial collagen types, which is another consequence ofThe likely stimulus underlying progressive podocyte
damage and renal failure in fa/fa-rats is hyperlipidemia. mesangial cell activation [31]. Our data are also consis-
tent with in vivo observations in type II diabetic GK-rats,In vitro glomerular epithelial cells express lipoprotein
receptor activity and respond to lipoprotein binding by in which life-long mild hyperglycemia failed to induce
mesangial activation and matrix accumulation [41]. Theincreasing their production of transforming growth
factor-b and fibronectin [42–44]. In vivo hypercholester- only evidence of some mesangial cell activation in our
study was a mild increase of mesangial ICAM-1 expres-olemia in rats is associated with the development of
FSGS [45]. We also recently reported that analbumi- sion in fa/fa-rats aged 14 weeks and older.
Using the expression of vimentin to detect proximalnemic rats with isolated hypertriglyceridemia, which in
young fa/fa-rats was more pronounced than hypercholes- tubular injury [27, 58] and a-smooth muscle actin as a
marker for interstitial fibroblast activation [30], we showterolemia (Table 1), slowly develop podocyte damage
and glomerulosclerosis [46]. Furthermore, up-regulation that tubulointerstitial damage appears to occur second-
arily to glomerular damage in young fa/fa-rats (Table 5).of plasma triglyceride levels by estrogen administration
aggravates renal damage in fa/fa-rats [32], and vice versa, This assumption is strengthened by the strong correla-
tion of podocytic desmin overexpression and tubular detherapeutic reduction of hyperlipidemia with fish oil, clo-
fibric acid, or a cholesterol synthesis inhibitor, mevinolin, novo vimentin expression. Proximal tubular damage oc-
curring at week 14 in fa/fa-rats has also been documentedall led to reduced FSGS development [9, 47].
The second very early pathologic event in kidneys of using the expression of clusterin [59]. The secondary
character of tubulointerstitial damage is supported byfa/fa-rats was a glomerular influx of monocytes/macro-
phages (Table 5), which is in agreement with previous our observation that vimentin-positive tubules near glo-
meruli with a normal desmin staining pattern were rarelyreports [12, 14]. This finding is not specific for fa/fa-rats,
as increased glomerular monocyte/macrophage counts detected, whereas the combination of desmin positive
podocytes and (still?) vimentin-negative adjacent tu-have been observed in cholesterol-fed and nephrotic, hy-
perlipidemic rats as well [48–50]. Thus, increased glomeru- bules occurred frequently in young rats (Table 3).
In conclusion, using sensitive markers of cellular dam-lar leukocyte counts may represent a nonspecific response
to hyperlipidemia, particularly hypercholesterolemia, and age and activation, we propose that progressive renal
disease in fa/fa-rats is characterized by early injury tomay relate to cholesterol-induced chemoattractant pro-
duction in glomerular cells [51]. Although it is conceiv- podocytes but not mesangial cells and is associated with
glomerular monocyte/macrophage influx and hypertro-able that the early monocyte/macrophage influx contrib-
utes to podocyte damage, for example, via production phy, as well as with secondary tubulointerstitial damage.
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a specific marker for rhabdomyosarcomas of human and rat origin.Subsequent late findings in damaged kidneys of fa/fa-
Am J Pathol 118:85–95, 1985
rats (Table 5), such as increased cell proliferation and 19. Osborn M, Debus E, Weber K: Monoclonal antibodies specific
for vimentin. Eur J Cell Biol 34:137–143, 1984matrix accumulation, exhibit considerable similarity to
20. Gonchoroff NJ, Katzmann JA, Currie RM, Evans EL, Houckthose in other models of progressive renal disease, for
DW, Kline BC, Greipp PR, Loken MR: S-phase detection with
example, subtotal nephrectomy or MNS rats [22, 35, 60], an antibody to bromodeoxyuridine: Role of DNase pretreatment.
J Immunol Methods 93:97–101, 1986suggesting that a relatively nonspecific common final
21. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity ofpathway of renal damage is entered.
mononuclear phagocytes in lymphoid organs: Distinct macrophage
subpopulations in the rat recognized by monoclonal antibodies
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